165 related articles for article (PubMed ID: 15757637)
1. Neuroprotective effects of an estratriene analog are estrogen receptor independent in vitro and in vivo.
Perez E; Liu R; Yang SH; Cai ZY; Covey DF; Simpkins JW
Brain Res; 2005 Mar; 1038(2):216-22. PubMed ID: 15757637
[TBL] [Abstract][Full Text] [Related]
2. Role of nonfeminizing estrogen analogues in neuroprotection of rat retinal ganglion cells against glutamate-induced cytotoxicity.
Kumar DM; Perez E; Cai ZY; Aoun P; Brun-Zinkernagel AM; Covey DF; Simpkins JW; Agarwal N
Free Radic Biol Med; 2005 May; 38(9):1152-63. PubMed ID: 15808412
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotective effects of a novel non-receptor-binding estrogen analogue: in vitro and in vivo analysis.
Liu R; Yang SH; Perez E; Yi KD; Wu SS; Eberst K; Prokai L; Prokai-Tatrai K; Cai ZY; Covey DF; Day AL; Simpkins JW
Stroke; 2002 Oct; 33(10):2485-91. PubMed ID: 12364742
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotective effects of R,R-tetrahydrochrysene against glutamate-induced cell death through anti-excitotoxic and antioxidant actions involving estrogen receptor-dependent and -independent pathways.
Xia Y; Xing JZ; Krukoff TL
Neuroscience; 2009 Aug; 162(2):292-306. PubMed ID: 19410635
[TBL] [Abstract][Full Text] [Related]
5. The estrogen receptor is not essential for all estrogen neuroprotection: new evidence from a new analog.
Xia S; Cai ZY; Thio LL; Kim-Han JS; Dugan LL; Covey DF; Rothman SM
Neurobiol Dis; 2002 Apr; 9(3):282-93. PubMed ID: 11950274
[TBL] [Abstract][Full Text] [Related]
6. Estrogen receptor-independent neuroprotection via protein phosphatase preservation and attenuation of persistent extracellular signal-regulated kinase 1/2 activation.
Yi KD; Cai ZY; Covey DF; Simpkins JW
J Pharmacol Exp Ther; 2008 Mar; 324(3):1188-95. PubMed ID: 18089844
[TBL] [Abstract][Full Text] [Related]
7. Role of nonfeminizing estrogens in brain protection from cerebral ischemia: an animal model of Alzheimer's disease neuropathology.
Simpkins JW; Wen Y; Perez E; Yang S; Wang X
Ann N Y Acad Sci; 2005 Jun; 1052():233-42. PubMed ID: 16024766
[TBL] [Abstract][Full Text] [Related]
8. Effect of halogenated substituents on the metabolism and estrogenic effects of the equine estrogen, equilenin.
Liu X; Zhang F; Liu H; Burdette JE; Li Y; Overk CR; Pisha E; Yao J; van Breemen RB; Swanson SM; Bolton JL
Chem Res Toxicol; 2003 Jun; 16(6):741-9. PubMed ID: 12807357
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of antioxidant and neuroprotective effect of ethanolic extract of Embelia ribes Burm in focal cerebral ischemia/reperfusion-induced oxidative stress in rats.
Nazam Ansari M; Bhandari U; Islam F; Tripathi CD
Fundam Clin Pharmacol; 2008 Jun; 22(3):305-14. PubMed ID: 18485149
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotective effects of estrone on NMDA-induced toxicity in primary cultures of rat cortical neurons are independent of estrogen receptors.
Kajta M; Lasoń W; Bień E; Marszał M
Pol J Pharmacol; 2002; 54(6):727-9. PubMed ID: 12866733
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and evaluation of B-, C-, and D-ring-substituted estradiol carboxylic acid esters as locally active estrogens.
Labaree DC; Zhang JX; Harris HA; O'Connor C; Reynolds TY; Hochberg RB
J Med Chem; 2003 May; 46(10):1886-904. PubMed ID: 12723952
[TBL] [Abstract][Full Text] [Related]
12. Design and synthesis of aryl diphenolic azoles as potent and selective estrogen receptor-beta ligands.
Malamas MS; Manas ES; McDevitt RE; Gunawan I; Xu ZB; Collini MD; Miller CP; Dinh T; Henderson RA; Keith JC; Harris HA
J Med Chem; 2004 Oct; 47(21):5021-40. PubMed ID: 15456246
[TBL] [Abstract][Full Text] [Related]
13. A nonfeminizing estrogen analog protects against ethanol withdrawal toxicity in immortalized hippocampal cells.
Jung ME; Wilson AM; Simpkins JW
J Pharmacol Exp Ther; 2006 Nov; 319(2):543-50. PubMed ID: 16873607
[TBL] [Abstract][Full Text] [Related]
14. Involvement of gamma protein kinase C in estrogen-induced neuroprotection against focal brain ischemia through G protein-coupled estrogen receptor.
Hayashi S; Ueyama T; Kajimoto T; Yagi K; Kohmura E; Saito N
J Neurochem; 2005 May; 93(4):883-91. PubMed ID: 15857391
[TBL] [Abstract][Full Text] [Related]
15. Thalidomide protects against ischemic neuronal damage induced by focal cerebral ischemia in mice.
Hyakkoku K; Nakajima Y; Izuta H; Shimazawa M; Yamamoto T; Shibata N; Hara H
Neuroscience; 2009 Mar; 159(2):760-9. PubMed ID: 19166916
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the neuroprotective effects of estrogens on hydrogen peroxide-induced cell death in hippocampal HT22 cells: time and dose-dependency.
Vedder H; Teepker M; Fischer S; Krieg JC
Exp Clin Endocrinol Diabetes; 2000; 108(2):120-7. PubMed ID: 10826519
[TBL] [Abstract][Full Text] [Related]
17. Reduction in oxidative stress and cell death explains hypothyroidism induced neuroprotection subsequent to ischemia/reperfusion insult.
Rastogi L; Godbole MM; Ray M; Rathore P; Rathore P; Pradhan S; Gupta SK; Pandey CM
Exp Neurol; 2006 Aug; 200(2):290-300. PubMed ID: 16616921
[TBL] [Abstract][Full Text] [Related]
18. Evidence for neuroprotection by the fenamate NSAID, mefenamic acid.
Khansari PS; Halliwell RF
Neurochem Int; 2009 Dec; 55(7):683-8. PubMed ID: 19563851
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the pharmacologic profile of a standardized soy extract in the ovariectomized rat model of menopause: effects on bone, uterus, and lipid profile.
Gallo D; Zannoni GF; Apollonio P; Martinelli E; Ferlini C; Passetti G; Riva A; Morazzoni P; Bombardelli E; Scambia G
Menopause; 2005; 12(5):589-600. PubMed ID: 16145313
[TBL] [Abstract][Full Text] [Related]
20. Anti-oxidant activity mediated neuroprotective potential of trimetazidine on focal cerebral ischaemia-reperfusion injury in rats.
Dhote V; Balaraman R
Clin Exp Pharmacol Physiol; 2008 May; 35(5-6):630-7. PubMed ID: 18318745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
